Scientific Committee 


Dr. Ghazwa B. Korayem 

Dr. Ghazwa is an Associate Professor at the College of Pharmacy, Princess Nourah bint Abdulrahman University (PNU). She earned her bachelor of pharmaceutical science degree from King Saud University in Saudi Arabia and her PharmD from Nova Southeastern University in the U.S. She completed her PGY-1 and PGY-2 in internal medicine at the University of Arizona Medical Center. She is also a Board Certified Pharmacotherapy Specialist pharmacist. In 2017, she was appointed as the College of Pharmacy Vice Dean of PNU, then the Acting Dean of the College of Pharmacy until 2019. Dr. Ghazwa currently works as a consultant internal medicine clinical pharmacist at King Abdulla bin Abdulaziz University Hospital. In 2020, Dr. Ghazwa was elected to be the Chairperson of the internal medicine specialized network (PSN) board under the umbrella of the Saudi society of clinical pharmacy. she has several publications focused on internal medicine, solid organ transplantation, COVID-19, and pharmacy education.  

Dr. Ghassan Al Ghamdi, MD, MME

Dr. Ghassan is a Board-certified Consultant with more than ten years of experience in Critical Care Medicine and Nephrology. Dr. Ghassan has a particular interest and demonstrated experience in Medical Education, especially postgraduate education with a Master's degree in Medical Education. He is the Associate Dean of Postgraduate Education and the Director of medical education at King Saud bin Abdulaziz University For Health Sciences.”

Dr. Ghassan has a vast work experience in Academic, Community, and Tertiary Hospital settings for institutions in both Governmental and Private sectors. Skilled in Critical Care Medicine, Nephrology, Internal Medicine, Critical thinking, Mentorship, Healthcare Leadership, Clinical Research, and Medical Education. Dr. Ghassan's research interests in critically ill patients have developed despite a full-time critical care practice. He is actively involved in research and has several publications in peer-reviewed journals.  

Dr. Hisham Badreldin

Dr. Badreldin is an Associate Professor at King Saud bin Abdulaziz University for Health Sciences, Research Affiliate at King Abdullah International Medical Research Center, and Cardiovascular Pharmacotherapy Consultant at King Abdulaziz Cardiac Center at the National Guard Health Affairs, Riyadh, Saudi Arabia. Dr. Badreldin was named a Fellow of the American College of Chest Physicians. Dr. Badreldin is a board-certified pharmacotherapy specialist and board-certified cardiology specialist, certified hypertension clinician, and certified anticoagulation specialist. Dr. Badreldin received many national and international awards for his clinical practice and research contributions. Dr. Badreldin authored numerous peer-reviewed articles and book chapters and led several research projects at the national and international levels. In addition, Dr. Badreldin serves on many national and international scientific regulatory and advisory committees and editorial boards for several reputable peer-reviewed biomedical journals.

Dr. Abdulrahman Alshaya

Dr. Alshaya currently serves as an Assistant Dean of Clinical Affairs and an Assistant Professor in the Pharmacy Practice Department in the College of Pharmacy (COP) at King Saud Bin Abdulaziz for Health Sciences. Additionally, he is a Critical Care Clinical Pharmacist at King Abdulaziz Medical City Riyadh. He earned his Bachelor degree in Pharmaceutical Sciences from King Saud University and his doctor of pharmacy degree from the university of Tennessee for health sciences center (UTHSC) before the end of 2017. Later, he completed an ASHP accredited PGY-1 from Brigham and Women’s Hospital (BWH) and an ASHP accredited PGY-2 in Critical Care Pharmacotherapy from BWH, a Harvard affiliated hospital, Boston, USA. Dr. Alshaya is American board certified in pharmacotherapy and critical care. He is actively involved in as a member of multiple scientific and organizing committees in national and international conferences. He publishes in critical care related topics in peer reviewed journals and presented multiple critical care related topics at various conferences inside and outside Saudi Arabia. He currently serves as the Treasurer for the Critical Care and Emergency Medicine Pharmacy Specialty Network and an Assistant Editor for the Saudi Journal of Clinical Pharmacy. 

Dr. Hakeam A. Hakeam

Dr. Hakeam Hakeam, is a Clinical Pharmacy Specialist, and a part-time Clinical Researcher specializing in the pharmacotherapy of surgical patients at King Faisal Specialist Hospital and Research Centre (KFSH & RC). In addition, Hakeam has been acting as a Team Leader for the Anticoagulation Clinic at KFSH & RC since June 2022.   Graduated from College of Pharmacy, King Saud University (KSU) with a baccalaureate degree in general pharmaceutical science. Immediately, joined KFSH & RC.  Acted as a staff pharmacist at various sections of the Department of Pharmaceutical Care till the recipient of a scholarship in 2001. Graduated with a Master’s Degree in Clinical Pharmacy, College of Pharmacy, KSU. Hakeam received a one-year training in KFSH & RC for PN, focusing on surgical patients. In 2010, Hakeam became a Pharmacotherapy Board Certified Specialist by BSP. Appointed as an Adjunct Assistant Professor, College of Medicine, Alfaisal University, 2016, and promote to an Associate Professor in 2021. Published many scientific articles in highly recognized international journals. Presented many presentations at international events inside and outside the Kingdom of Saudi Arabia. A member of institutional research committees for the Department of Surgery and the Department of Critical Care Medicine. Nationally, appointed as a member of the steering committee for the Saudi Pharmacy Licensure Exam (SPLE).  On 2019 appointed as a Chairman of the Biomedical Science Sub-committee of the SPLE, until May 2020.

Dr. Hadeel Alkofide

Dr. Hadeel Alkofide is an assistant professor at the Clinical Pharmacy Department, King Saud University. In addition, she works as a consultant for the Saudi Food and Drug Administration (SFDA). Dr. Alkofide is also the head of the Scientific Advisory Committee for Clinical Studies at the SFDA. Dr. Alkofide has received her Ph.D. degree in Clinical and Translational Sciences from Tufts University, United States. Dr. Alkofide’s primary areas of research interests include clinical trials and their related regulations, including the ethical aspects of clinical trials, as well as evidence-based methods for a variety of clinical topics and multiple treatment comparisons, and meta-epidemiological studies. 

Dr. Abdullah M. Alhammad

Dr. Abdullah M. Alhammad is an Associate Professor of Clinical Pharmacy at the College of Pharmacy, King Saud University (KSU), Riyadh, Saudi Arabia. In 2017, he held an appointment as a manager of clinical pharmacy services and drug information and poisoning center at King Khalid University Hospital (KKUH)-King Saud University Medical City (KSUMC). Over the last decade, he has served as the clinical pharmacy consultant in adult critical care services and percepts pharmacy interns and residents. He also served as the PGY-1 pharmacy residency program director for three years. He has been the director of the adult critical care pharmacy residency program in KSUMC since 2016. He is a board-certified pharmacotherapy specialist and board-certified critical care pharmacist by the Board of Pharmacy Specialties. His research/scholarship focuses on advancing pharmacy education and training, exploring and evaluating pharmacy practices and quality of life in adult critically ill patients.

Dr. Khalid Eljaaly

Khalid Eljaaly is an associate professor in the faculty of pharmacy and head of the health interprofessional research branch in the university vice-presidency for development at King Abdulaziz University, Jeddah, Saudi Arabia. He is a consultant infectious disease pharmacist and director of the infectious disease pharmacy residency program at King Abdulaziz University Hospital. Dr. Eljaaly was the chairman of the infectious disease pharmacy specialty network of the Saudi Society of Clinical Pharmacy (SSCP) between 2020 and 2022. He is also an honorary research fellow in the college of pharmacy at the University of Arizona, Tucson, AZ, USA. He completed his PGY1 pharmacy practice residency at SEMC, a Tuft-University affiliated hospital, and his PGY2 infectious disease pharmacy residency at BIDMC, a Harvard Medical School-affiliated hospital in Boston, MA, USA. Then, he completed both an antibiotic stewardship pharmacy fellowship and a Master of Science in clinical translational research at the University of Arizona. He was a member of the American College of Clinical Pharmacy scientific program committee of the 2022 global conference on clinical pharmacy. Dr. Eljaaly is a member of the editorial advisory board of Contagion®, Saudi Journal of Clinical Pharmacy, which is owned by SSCP, Antimicrobial Stewardship & Healthcare Epidemiology (ASHE), which is owned by the Society of Healthcare Epidemiology of America (SHEA), and Frontiers in Antibiotics.

Dr. Abdullah Alrajhi

Dr. Abdullah is a Hematology/Bone Marrow Transplant clinical pharmacist at King Fahad Medical City, and a Senior lecturer at College of Pharmacy - AlFaisal University. He serves as a member in multiple committees at the hospital, SFDA, and other organizations. Dr. Abdullah received his Bachelor of Pharmaceutical Science from the College of Pharmacy, King Saud University, in 2011. He then worked for two years as a staff pharmacist in an oncology pharmacy at King Fahad Medical City. Dr. Abdullah completed his Doctor of Pharmacy from MCPHS University, Boston, the United States. He completed his PGY1 residency at MelroseWakfield Hospital, Boston, the United States in 2018, and PGY2 in oncology/hematology at King Faisal Specialist Hospital and Research Centre in 2020.   Dr. Abdullah published multiple articles on lymphoma, leukemia, and benign hematological disease. Dr. Abdullah's current research areas of interest are; hematological malignancies, hematopoietic stem cell transplantation and ID in immunocompromised patients.   

Dr. Abrar Thabit

Dr.  Abrar is an associate professor in Infectious Diseases Pharmacotherapy at the Faculty of Pharmacy of King Abdulaziz University, Jeddah, Saudi Arabia. In addition, she is a Consultant infectious diseases pharmacist. She completed PGY1 Pharmacy Practice Residency at Massachusetts General Hospital, Boston, Massachusetts, USA. Therafter, Dr. Abrar completed PGY2 Infectious Diseases Pharmacy Residency at the University of Houston and Cardinal Health, Houston, Texas, USA. Moreover, she completed Infectious Diseases Research Fellowship at the Center for Anti-Infective Research and Development of Hartford Hospital, Hartford, Connecticut, USA. Later, Dr. Abrar completed a certificate program on Infectious Diseases in Adults at Harvard Medical School, Boston, Massachusetts, USA. Recently, she completed a certificate program on clinical research at Boston University, Boston, Massachusetts, USA.

Dr. Nouf Alotaibi

Dr. Nouf Alotaibi is assistant professor and Solid organ transplant clinical pharmacist consultant. She completed her Pharm.D degree from king Saud university in 2014. Dr. Alotaibi completed her postgraduate studies at King Abdulaziz Medical City-Riyadh. She completed PGY-1 in 2016, which has been accredited by the SCFHS and the American society of health system pharmacists (ASHP) and completed her PGY-2 in Solid organ transplant at King Abdulaziz Medical City in 2017 and became a board-certified pharmacotherapy and nutrition support by American Board of Pharmacy Specialties (BPS). Dr. Alotaibi worked as a solid organ transplant clinical pharmacist at king Faisal specialist hospital and research center in Jeddah since 2018 till January 2020, then she became assistant professor at Umm- Al Qura university since 2020 till now    Also, Dr. Alotaibi worked at king Abdullah medical city in Makkah since February 2020-till now. Dr. Alotaibi has several publications in era of transplantation. Moreover, she served as a peer-reviewer for several journals. Dr. Alotaibi is a member of Saudi commission for heath specialty matching system for CV evaluation committee since 2019   Member of the Curriculum Development Committee for the Fellowship Program in Solid Organ Transplant pharmacotherapy. Dr. Alotaibi is examiner in the final exams of the fellowship programs. Moreover, Dr. Alotaibi is a member of the total parenteral nutrition fellowship examiner committee at Saudi commission for health specialty. Dr Alotaibi has ASHP teaching certificate for pharmacist.